A randomized, double-blind, single-dose study, placebo-controlled evaluation of the safety and efficacy of intravenous lornoxicam in the acute treatment of the headache of migraine.
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2012
At a glance
- Drugs Lornoxicam (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors POZEN
- 30 Nov 2012 Actual end date Apr 2006 added as reported by ClinicalTrials.gov.
- 23 Oct 2006 New trial record.